Bal Pharma Stock Screener | Share Price & Fundamental Analysis
BALPHARMA
Pharmaceuticals
Share Price NSE
₹75.28
▼
-0.93 (-1.22%)
Share Price BSE
₹74.79
▼
-1.38 (-1.81%)
Track Bal Pharma share price live with TickJournal's free stock screener.
Analyze Bal Pharma share price history trends and compare 52-week high low
levels.
Calculate BALPHARMA stock fair value using fundamental analysis and view live share price charts.
Determine Bal Pharma share intrinsic value and compare it with current BALPHARMA share price.
Record your Bal Pharma trades in TickJournal's free trading journal and track your portfolio performance.
Bal Pharma Market Cap
₹116.49 Cr.
Bal Pharma P/B Ratio
1.52
EPS (TTM)
₹4.54
Dividend Yield
1.60%
Debt to Equity
1.94
BALPHARMA 52 Week High
₹122.23
Bal Pharma 52 Week Low
₹66.40
Operating Margin
9.00%
Profit Margin
6.02%
BALPHARMA Revenue (TTM)
₹83.00
EBITDA
₹9.00
Net Income
₹5.00
Total Assets
₹336.00
Total Equity
₹77.00
Bal Pharma Share Price History - Stock Screener Chart
Screen BALPHARMA historical share price movements with interactive charts. Analyze price trends and patterns.
Bal Pharma Company Profile - Fundamental Screener
Screen Bal Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BALPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE083D01012
Bal Pharma Balance Sheet Screener
Screen BALPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 336 | 320 | 313 | 261 | 240 | 238 | 261 | 260 | 233 | 211 |
| Current Assets | 235 | 234 | 228 | 185 | 164 | 157 | 183 | 185 | 165 | 143 |
| Fixed Assets | 87 | 80 | 77 | 67 | 69 | 71 | 70 | 72 | 60 | 56 |
| Liabilities | ||||||||||
| Total Liabilities | 336 | 320 | 313 | 261 | 240 | 238 | 261 | 260 | 233 | 211 |
| Current Liabilities | 39 | 45 | 40 | 36 | 34 | 34 | 38 | 46 | 30 | 45 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 77 | 72 | 64 | 59 | 53 | 45 | 60 | 60 | 60 | 55 |
| Share Capital | 16 | 16 | 16 | 15 | 15 | 14 | 14 | 14 | 14 | 13 |
| Reserves & Surplus | 62 | 56 | 48 | 43 | 38 | 38 | 53 | 51 | 48 | 40 |
Bal Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Bal Pharma income statement and profit fundamentals.
Analyze BALPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Bal Pharma share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 83 | 67 | 75 | 97 | 75 | 74 | 74 | 83 | 71 | 93 | 82 | 78 | 70 | 75 | 77 |
| Expenses | 74 | 60 | 68 | 85 | 68 | 66 | 65 | 74 | 64 | 85 | 74 | 71 | 65 | 70 | 71 |
| EBITDA | 9 | 7 | 7 | 12 | 7 | 8 | 8 | 8 | 7 | 8 | 8 | 7 | 5 | 6 | 7 |
| Operating Profit % | 9.00% | 9.00% | 8.00% | 10.00% | 9.00% | 10.00% | 11.00% | 10.00% | 9.00% | 8.00% | 10.00% | 5.00% | 7.00% | 8.00% | 8.00% |
| Depreciation | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 3 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 3 | 2 | 3 | 3 |
| Profit Before Tax | 3 | 0 | 1 | 6 | 1 | 1 | 1 | 2 | 0 | 2 | 1 | 2 | 1 | 1 | 1 |
| Tax | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
| Net Profit | 5 | 0 | 1 | 6 | 0 | 1 | 1 | 2 | 0 | 1 | 1 | 2 | 0 | 0 | 1 |
| EPS | 3.40 | 0.13 | 0.45 | 3.73 | 0.16 | 0.65 | 0.33 | 1.03 | 0.06 | 0.62 | 0.54 | 1.33 | 0.19 | 0.08 | 0.38 |
Bal Pharma Cash Flow Screener - Liquidity Fundamentals
Screen BALPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 20 | 23 | -2 | 27 | 22 | 23 | 8 | 1 | 6 | -19 |
| Investing Activities | -15 | -19 | -22 | -10 | -6 | -5 | -8 | -4 | -8 | -14 |
| Financing Activities | -8 | -1 | 24 | -17 | -17 | -20 | 0 | 4 | -6 | 32 |
| Net Cash Flow | -2 | 3 | 0 | 0 | 0 | -2 | 0 | 1 | -8 | -1 |
Bal Pharma Shareholding Pattern Screener
See Bal Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Bal Pharma promoter holding and ownership changes for BALPHARMA on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.86% | 50.86% | 50.86% | 51.23% | 51.23% | 50.86% | 50.86% | 51.61% |
| FII Holding | 0.14% | 0.15% | 0.22% | 0.13% | 0.13% | 0.13% | 0.14% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.49% | 32.41% | 32.97% | 32.15% | 32.36% | 33.15% | 32.57% | 32.07% |
| Other Holding | 16.51% | 16.58% | 15.94% | 16.49% | 16.28% | 15.86% | 16.43% | 16.32% |
| Shareholder Count | 15,723 | 15,826 | 15,774 | 14,772 | 15,014 | 16,007 | 15,667 | 16,029 |
Bal Pharma Share Dividend Screener - Share Yield Analysis
Check Bal Pharma dividend history with payout and yield data.
View Bal Pharma dividend details including ex-dates and amounts for BALPHARMA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.20 | 1.62% |
| 2024-March | ₹1.20 | 1.43% |
| 2023-March | ₹1.00 | 1.10% |
| 2022-March | ₹1.00 | 1.55% |
| 2021-March | ₹1.00 | 0.93% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 3.13% |
| 2018-March | ₹1.00 | 1.43% |
| 2017-March | ₹1.00 | 1.30% |
| 2016-March | ₹0.00 | 0.00% |
Bal Pharma Stock Index Membership
See which indices include Bal Pharma stock.
Check BALPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Bal Pharma Market Events Screener - Corporate Actions
Get Bal Pharma corporate actions including splits, bonuses, and buybacks.
Check Bal Pharma stock events that may affect BALPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.20 /share | -6.50% | ||
| Dividend | ₹ 1.00 /share | -1.36% | ||
| Dividend | ₹ 1.00 /share | 10.53% | ||
| Dividend | ₹ 1.00 /share | 6.91% | ||
| Dividend | ₹ 1.20 /share | 31.47% | ||
| Annual General Meeting | NA | 14.26% | ||
| Annual General Meeting | NA | -9.36% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -1.70% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -3.59% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -6.14% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -12.62% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.93% |
| 2023-12-21 | 2023-12-21 | Extraordinary General Meeting | NA | -10.17% |
Bal Pharma Competitors Screener - Peer Comparison
Screen BALPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Bal Pharma Company Announcements - News Screener
Screen BALPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Unaudited Financial Results For The Quarter Ended 30.09.2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting_12.11.2025 | View |
| 2025-11-07 | Update On The Outcome Of The Board Meeting Held On 11.08.2025 | View |
| 2025-11-04 | Board Meeting Intimation for Unaudited Financial Results | View |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-02 | Reg. 34 (1) Annual Report. | View |
| 2025-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-12 | Corporate Action-Fixes Record Date For Dividend. | View |
| 2025-08-11 | Unaudited Financial For The Quarter Ended 30.06.2025. | View |
| 2025-08-11 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-07-29 | Board Meeting Intimation for Inter Alia Take On Record And Approve The Unaudited Financial Results For The Quarter Ended 30.06.2025. | View |
| 2025-07-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-07-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-07-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-06-30 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |